Mannatech Q2 10-Q Reveals Going Concern Doubt and Nasdaq Equity Deficiency

summarizeSummary

Mannatech's Q2 10-Q discloses going concern doubt, a Nasdaq equity deficiency, and a cyber incident, despite reporting a $1.0 million quarterly profit.

check_boxKey Events · Earnings and Guidance · MTEX

• Going Concern Doubt

  Management states substantial doubt about the company's ability to continue as a going concern within one year, citing decline in net sales, operating losses, negative cash flows, and an organizational structure no longer aligned with current operating scale.

• Nasdaq Equity Deficiency

  Company received notice on April 20, 2026 of non-compliance with Nasdaq Listing Rule 5550(b)(1) (minimum stockholders' equity of $2,500,000); submitted a compliance plan on June 4, 2026 and provided additional information on July 14, 2026.

• Cyber Incident

  During Q2 2026, a cyber incident resulted in potential exposure of personal information of certain independent associates and customers; investigation ongoing, no litigation filed.

• Cost-Cutting Measures

  Director compensation converted to equity (expected $0.8M annual cash preservation), headcount reductions, and facilities/overhead actions effective March 31, 2026.

auto_awesomeAnalysis · MTEX · Life Sciences

Mannatech's Q2 10-Q discloses that management has substantial doubt about the company's ability to continue as a going concern within one year, citing declining sales, operating losses, and negative cash flows. The company also remains out of compliance with Nasdaq's minimum stockholders' equity rule, having received a deficiency notice on April 20, 2026 and submitted a compliance plan on June 4, 2026. While the quarter showed a net profit of $1.0 million, the profit was driven largely by a $0.3 million foreign currency gain, and the company's cash position remains tight at $6.0 million. The filing also reveals a cyber incident and cost-cutting measures, including converting director compensation to equity.